Skip to main content

Table 2 Subject demographics and clinical characteristics

From: Demographic profile, clinical features, and outcome of peripapillary subretinal hemorrhage: an observational study

 Group 1Group 2Group 3Totalp# value
PSHPSH + IPHPSH + IPH + VH
(na = 4)(n = 17)(n = 17)(n = 38)
Age (years)     
Mean ± SD18.75 ± 7.5022.12 ± 8.8918.29 ± 5.6020.05 ± 7.47ptotal0.315
Range15–3010–3911–3110–39 
Gender, N (%)     
Male3 (75%)2 (11.8%)7 (41.2%)12 (31.6%)b 
Female1 (25%)15 (88.2%)10 (58.8%)26 (68.4%) 
Risk factor13610 
Male1124c 
Female0246 
Myopia (Diopters)     
Mean ± SD2.88 ± 1.093.28 ± 1.393.57 ± 2.243.37 ± 1.77ptotal0.758
Range2.00–4.251.75–7.001.25–9.001.25–9.00  
BCVA (LogMAR)     
Visit 0 (Mean ± SD)−0.02 ± 0.110.13 ± 0.170.46 ± 0.500.26 ± 0.39ptotal0.012
p120.16
p130.01
p230.05
Endpoint (Mean ± SD)−0.06 ± 0.08−0.03 ± 0.090.01 ± 0.06−0.02 ± 0.08ptotal0.189
Duration of absorption (months)     
Mean ± SD2.00 ± 0.822.53 ± 1.073.59 ± 1.422.95 ± 1.33ptotal0.018
p13 < 0.05
p12 > 0.05
p23 > 0.05
Range1–31–42–61–6  
Recurrence0000 
  1. BCVA best-corrected visual acuity, IPH intrapapillary hemorrhage, PSH peripapillary subretinal hemorrhage, SD standard deviation, VH vitreous hemorrhage
  2. #: ptotal: p value of comparison among all groups; p12: p value of comparison between Group 1 and Group 2; p13: p value of comparison between Group 1 and Group 3; p23: p value of comparison between Group 2 and Group 3
  3. aAffected eyes
  4. bOne male both eyes affected
  5. cBilateral eyes affected man, his right eye in Group 1, his left eye in Group 3